Team:Calgary/PoliciesAndPractices/FIND

From 2014.igem.org

(Difference between revisions)
Line 6: Line 6:
<img src="https://static.igem.org/mediawiki/2014/c/c5/2014UCalgaryFIND.jpg" align="left">
<img src="https://static.igem.org/mediawiki/2014/c/c5/2014UCalgaryFIND.jpg" align="left">
<p>While abroad attending the BTWc, the iGEM Calgary arranged a meeting the Foundation for Innovative New Diagnostics (FIND), the foremost authority on non-profit diagnostic systems internationally. We sought to meet with them to better understand the world of diagnostics, as well as seeking their opinion regarding the feasibility and demand for the proposed device.  
<p>While abroad attending the BTWc, the iGEM Calgary arranged a meeting the Foundation for Innovative New Diagnostics (FIND), the foremost authority on non-profit diagnostic systems internationally. We sought to meet with them to better understand the world of diagnostics, as well as seeking their opinion regarding the feasibility and demand for the proposed device.  
-
<\p>
 
<p>
<p>
Their meeting with Dr. Ranald Sutherland proved to be insightful and informative. We learned how you could expect that the consumer cost of a device will be nearly double that of production costs once all taxes and fees are levied. He also advised the team to redirect their focus from being simply a multidiagnostic, to a ‘reflex test’. A ‘reflex test’ would be administered only when presented with a negative diagnosis from a rapid malaria diagnostic, which functions much more quickly then the assay being designed. This is an important marketing tool, as if they were to try and compete with these already existing and highly efficient technologies, the project might not prevail.  
Their meeting with Dr. Ranald Sutherland proved to be insightful and informative. We learned how you could expect that the consumer cost of a device will be nearly double that of production costs once all taxes and fees are levied. He also advised the team to redirect their focus from being simply a multidiagnostic, to a ‘reflex test’. A ‘reflex test’ would be administered only when presented with a negative diagnosis from a rapid malaria diagnostic, which functions much more quickly then the assay being designed. This is an important marketing tool, as if they were to try and compete with these already existing and highly efficient technologies, the project might not prevail.  
 +
<p>
FIND has offered to be a continued resource for our team should they have any more concerns or questions. Their consultation has given the team a strategy for creating a novel, yet practical diagnostic tool.
FIND has offered to be a continued resource for our team should they have any more concerns or questions. Their consultation has given the team a strategy for creating a novel, yet practical diagnostic tool.

Revision as of 07:08, 10 October 2014

Foundation for Innovative New Diagnostics (FIND)

While abroad attending the BTWc, the iGEM Calgary arranged a meeting the Foundation for Innovative New Diagnostics (FIND), the foremost authority on non-profit diagnostic systems internationally. We sought to meet with them to better understand the world of diagnostics, as well as seeking their opinion regarding the feasibility and demand for the proposed device.

Their meeting with Dr. Ranald Sutherland proved to be insightful and informative. We learned how you could expect that the consumer cost of a device will be nearly double that of production costs once all taxes and fees are levied. He also advised the team to redirect their focus from being simply a multidiagnostic, to a ‘reflex test’. A ‘reflex test’ would be administered only when presented with a negative diagnosis from a rapid malaria diagnostic, which functions much more quickly then the assay being designed. This is an important marketing tool, as if they were to try and compete with these already existing and highly efficient technologies, the project might not prevail.

FIND has offered to be a continued resource for our team should they have any more concerns or questions. Their consultation has given the team a strategy for creating a novel, yet practical diagnostic tool.